Kaplan-Meier graphs for breast cancer incidence in the tamoxifen
4.8 (387) · $ 11.00 · In stock
2021 Update on Systemic Therapy for Breast Cancer Published in healthbook TIMES Oncology Hematology
Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis
Full article: Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming
Kaplan-Meier graphs for the disease-free and overall survival rates of
Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
JCM, Free Full-Text
Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
Figure 5 from Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.
Kaplan Meier breast cancer survival curve for CYP2D6*4 genotype.
